肺癌
趋化因子
癌变
癌症研究
免疫系统
癌症
免疫学
生物
肿瘤坏死因子α
发病机制
促炎细胞因子
医学
炎症
病理
遗传学
作者
Kevin James Baker,Emily Buskiewicz,Méabh Finucane,Adeleine Chelliah,Louise Burke,Aileen Houston,Elizabeth Brint
出处
期刊:Cytokine
[Elsevier BV]
日期:2023-03-15
卷期号:165: 156170-156170
被引量:7
标识
DOI:10.1016/j.cyto.2023.156170
摘要
The IL-36 cytokines are a recently described subset of the IL-1 family of cytokines, and have been shown to play a role in the pathogenesis of respiratory diseases such as asthma and COPD. Given the common aetiological links between COPD and lung cancer development, as well as the involvement of other IL-1 family members in lung tumorigenesis, the aim of this work was to investigate the role of IL-36 cytokines in the pathogenesis of lung cancer. In this study we demonstrate that expression of IL-36 cytokines and receptor mRNA and protein are significantly increased in lung cancer tissue compared to adjacent non-tumour tissue. In vitro assays showed that stimulation of two lung cancer cell lines, SKMES-1 human squamous cell and LLC murine lung cancer, with IL-36R agonists resulted in increased cellular migration and proliferation. All IL-36 cytokines induced the expression of pro-inflammatory chemokines in both lung cancer cell lines with synergistic effects identified upon co-stimulation of cells with IL-17, IL-22 and TNFα. Furthermore, we report that IL-36 cytokines induce protein expression of the immune checkpoint inhibitor protein PD-L1 on lung cancer cells. Taken together, this data indicates that targeting IL-36R signalling may be a useful targeted therapy for lung cancer patients with IL-36R+ cancer cells.
科研通智能强力驱动
Strongly Powered by AbleSci AI